|
PBL Assay
ifnβ ![]() Ifnβ, supplied by PBL Assay, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+interferon-beta+1b/Human+Interferon+Beta+1b%2C+E%2Ecoli/pmc12846703-10-18-20 Average 94 stars, based on 1 article reviews
ifnβ - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
ELISA for estimation of Human Interferon beta 1b, IFNB-1b in serum, plasma and other biological fluids
|
Buy from Supplier |
|
Gold Biotechnology Inc
immunofluorescence buffer Immunofluorescence Buffer, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+interferon-beta+1b/IFN-beta1B%2C+Human/pmc10235871-59-21-29 Average 93 stars, based on 1 article reviews
immunofluorescence buffer - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Barofold Inc
recombinant human ifn beta baroferontm Recombinant Human Ifn Beta Baroferontm, supplied by Barofold Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+interferon-beta+1b/recombinant+human+interferon+beta++rhifn+beta+1b/10__2147_slash_btt__s29948-67-14-0 Average 90 stars, based on 1 article reviews
recombinant human ifn beta baroferontm - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Enzon Inc
recombinant human interferon-beta-1b (30 miu/mg) Recombinant Human Interferon Beta 1b (30 Miu/Mg), supplied by Enzon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+interferon-beta+1b/recombinant+human+interferon+beta+1b++30+miu+mg+/pm16536464-60-0-8 Average 90 stars, based on 1 article reviews
recombinant human interferon-beta-1b (30 miu/mg) - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Interferon beta 1b Human Recombinant produced in E.Coli is a single, non-glycosylated mutein (variant form) of human Interferon beta-1b polypeptide chain containing 165 amino acids and having a molecular mass of 18510.86 Dalton.The IFN-beta gene
|
Buy from Supplier |
|
Interferon-Beta 1b, Human Recombinant; 10 ug
|
Buy from Supplier |
|
The Recombinant Human Interferon beta 1b Protein from Novus Biologicals is derived from E coli The Recombinant Human Interferon beta 1b Protein has been validated for the following applications Functional SDS Page
|
Buy from Supplier |
|
Purified recombinant Interferon beta 1b expressed in E. coli.
|
Buy from Supplier |
|
IFN b 1b; Recombinant Human Interferon-beta 1b; Recombinant Human Interferon-beta 1b
|
Buy from Supplier |
|
Purified recombinant Interferon beta 1b expressed in E. coli.
|
Buy from Supplier |
|
Interferon-Beta 1b, Human Recombinant; 10 ug
|
Buy from Supplier |
Image Search Results
Journal: Journal of Human Immunity
Article Title: Increased prevalence of autoantibodies neutralizing IFNλ2/3 in young individuals with cystic fibrosis
doi: 10.70962/jhi.20250268
Figure Lengend Snippet: At least 10% of young individuals with CF harbor neutralizing anti-IFNλ2/3 IgG autoAbs. (A) IFNλ1/2/3 neutralization by plasmas from individuals with AD ( n = 39), various adults (CT; n = 68), or pwCF (CF; n = 84 samples from n = 51 individuals). Dotted lines indicate thresholds set using standard outlier calculations. Neutralizing plasmas are orange; numbers represent unique individuals; positive individuals are labeled. (B) Anti-IFN-III and anti-IFN-I IgGs in CF plasmas positive (neut; n = 9) or negative (non-neut; n = 6) for IFNλ2/3 neutralization. (C) Spearman’s correlation between IFNλ2/3 neutralization (A) and IgG (B). (D) Anti-IFNλ2/3 IgG subclasses in CF plasmas ( n = 5). (E) Area under the curve from PIV5-GFP replication kinetics in A549 cells pretreated with IFNλ2 (or not) in the presence of pwCF plasmas positive (pos) or negative (neg) for IFNλ2/3 neutralization. Values are triplicate means from two experiments. Error bars indicate standard deviations. For the IFNλ2+pos and IFNλ2+neg groups, data are from two patients (squares/triangles) from two experiments. (F) Fluorescence images of infected cells from E. (G) Random forest regression of clinical variables in pwCF positive ( n = 4) or negative ( n = 16) for anti-IFNλ2/3 autoAbs. Dots represent importance scores per iteration (maximum 5,000); error bars reflect importance spread. Abbreviations: MFI FC, median fluorescence intensity fold-change; IVIG, intravenous immunoglobulin; IBD, inflammatory bowel disease; CFRD, CF-related diabetes; ABPA, allergic bronchopulmonary aspergillosis; SA, Staphylococcus aureus ; PA, Pseudomonas aeruginosa . Statistical analyses were two-way ANOVA with the Šidák correction (B), Spearman correlation (C), and Mann–Whitney test (E) (ns, nonsignificant; *P < 0.05; ****P < 0.0001).
Article Snippet: Protein targets were: IFNλ1 (NBP2-34996; Novusbio), IFNλ2 (8417-IL; R&D Systems), IFNλ3 (5259-IL; R&D Systems), IFNα2 (NBP2-34971, Novusbio), and
Techniques: Neutralization, Labeling, Fluorescence, Infection, MANN-WHITNEY
Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis
doi: 10.1002/jcsm.13214
Figure Lengend Snippet: Satellite cell reduction reduces muscle regeneration capacity in cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( A ) Timeline representing male Pax7‐DTA mice treated for five consecutive daily injections of tamoxifen or vehicle, 15 days before surgery. Percentage change from baseline of ( B ) lean mass. ( C ) Immunofluorescence images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross sections from either vehicle or tamoxifen control and CLP/DCS mice. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( D ) Pax7 staining (top) and quantification of Pax7‐positive nuclei per myofibre (bottom) of tibialis anterior (TA) cross‐sections from vehicle or tamoxifen control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = Two‐way ANOVA with Bonferroni multiple comparisons (BMC) where *significant vs. control vehicle and control tamoxifen, ^significant vs. control tamoxifen, and % significant vs. control vehicle, P < 0.05. C = nonlinear fit pairwise comparisons. D = One‐way ANOVA with BMC where significance = * P < 0.05, ** P < 0.01, *** P < 0.001. See Tables
Article Snippet: Permeabilization was performed using 0.5% Triton X‐100 (Sigma) in PBS for 5 min at room temperature (RT), then washed ×2 in
Techniques: Ligation, Immunofluorescence, Control, Staining
Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis
doi: 10.1002/jcsm.13214
Figure Lengend Snippet: Characterization of muscle loss and recovery in CLP/DCS mice. ( A ) Combined cecal ligation and puncture (CLP)/daily chronic stress (DCS) Kaplan–Meier survival curve versus control mice to experiment endpoint. ( B ) Serum levels of mouse C‐reactive protein (CRP) and aspartate aminotransferase (AST) activity. ( C ) Control and CLP/DCS percentage change from baseline in lean mass. Data from mouse MRI on Day 3 or 4 are represented on lean mass graph as Day 3. ( D ) Harvested wet weights, as change in percentage of control, of tibialis anterior (TA, top) and gastrocnemius (GR, bottom) normalized to baseline body weight, respectively, in control and CLP/DCS Days 4, 8 and 28. ( E ) Immunofluorescence images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross‐sections from control, Days 4, 8 and 28 CLP/DCS mice. Green = laminin, Blue = DAPI. Images are representative and ×20 with scale bar = 200 μm. See Table
Article Snippet: Permeabilization was performed using 0.5% Triton X‐100 (Sigma) in PBS for 5 min at room temperature (RT), then washed ×2 in
Techniques: Ligation, Control, Activity Assay, Immunofluorescence
Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis
doi: 10.1002/jcsm.13214
Figure Lengend Snippet: Muscle recovery deficit in post‐sepsis mice with secondary muscle injury. ( A ) Timeline depicting experimental setup of second insult to muscle in control and cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( B ) Immunofluorescence images (top) and minimum Feret diameter quantification (bottom) of tibialis anterior (TA) cross‐sections in control or CLP/DCS mice that received vehicle or BaCl 2 (injured) injections. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( C ) Pax7 staining (top) and quantification of Pax7‐postive nuclei per myofibre of TA cross‐sections from vehicle or injured control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = nonlinear fit pairwise comparisons, see Table
Article Snippet: Permeabilization was performed using 0.5% Triton X‐100 (Sigma) in PBS for 5 min at room temperature (RT), then washed ×2 in
Techniques: Control, Ligation, Immunofluorescence, Staining